International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease
Frits van Rhee(Winthrop Rockefeller Foundation), David C. Fajgenbaum(University of Pennsylvania), Simone Ferrero(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Jason R. Ruth(University of Pennsylvania), Makoto Ide(Takamatsu Red Cross Hospital), Kojo S.J. Elenitoba‐Johnson(Memorial Sloan Kettering Cancer Center), Vera P. Krymskaya(University of Pennsylvania), Raj Jayanthan(Baylor College of Medicine), Shanmuganathan Chandrakasan(Emory University), David Simpson(North Shore Hospital), Megan S. Lim(Memorial Sloan Kettering Cancer Center), Heather A. Leitch(University of British Columbia), Nikhil C. Munshi(Dana-Farber Cancer Institute), Thomas S. Uldrick(Regeneron (United States)), Razelle Kurzrock(Medical College of Wisconsin), Louis Terriou(Centre Hospitalier Universitaire de Lille), Alexander Fosså(Oslo University Hospital), Sheila K. Pierson(University of Pittsburgh Medical Center), Raymond Wong(Chinese University of Hong Kong), Kazuyuki Yoshizaki(Osaka Research Institute of Industrial Science and Technology), Amy D Greenway(University of Arkansas for Medical Sciences), Matthew Streetly(King's College - North Carolina), Yasuharu Sato(Okayama University), Amy Chadburn(Cornell University), Gordan Srkalović(Regional Cancer Center), Peter M. Voorhees(Levine Cancer Institute), Dustin Shilling(University of Pennsylvania), Mary Jo Lechowicz(Emory University), Corey Casper(University of Washington), Sunita D. Nasta(University of Pennsylvania), Naveen Pemmaraju(The University of Texas MD Anderson Cancer Center), Elaine S. Jaffe(National Cancer Institute), Pier Luigi Zinzani(Istituto di Ematologia di Bologna), Sudipto Mukherjee(Cleveland Clinic), Katie Stone(University of Arkansas for Medical Sciences), Christian Hoffmann(Hochschule für Angewandte Wissenschaften Kiel), Aaron M. Goodman(University of California San Diego), Helen Partridge(University of Toronto), Jean‐François Rossi(Inserm), Angela Dispenzieri(Mayo Clinic), Stephen Schey(University College Hospital), Éric Oksenhendler(Université Paris Cité)
Cited by 421
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
|Molecular Cancer Therapeutics|2017|2.4k
PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
|Molecular Cancer Therapeutics|2015|2.3k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k